Certification Rate
100%
7 H-1B petitions, 100% certified, $80,603 median salary, FY2024–2025.
SOUTH PLAINFIELD, NJ NAICS: 561320
The verdict
Globex Healthcare & Pharma Inc filed 7 H-1B petitions, more than 82% of U.S. sponsors - certified at 100% with a $80,603 median offered wage.
Based in SOUTH PLAINFIELD, NJ. Computed live from U.S. Department of Labor LCA disclosures.
H-1B sponsorship profile: Globex Healthcare & Pharma Inc. Across U.S. Department of Labor LCA disclosures, Globex Healthcare & Pharma Inc filed 7 Labor Condition Applications covering 7 H-1B worker positions between fiscal year 2024 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (7 certified of 7 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.
Compensation spread. Offered wages on Globex Healthcare & Pharma Inc’s H-1B petitions range from $61,069 at the low end to $108,306 at the high end, with a petition-weighted average of $80,603. That range reflects the mix of occupations the company sponsors, led by CLINICAL DATA MANAGER (3 petitions at $96,408 avg), followed by SAFETY & PHARMACOVIGILANCE SPECIALIST and REGULATORY AFFAIRS SPECIALIST. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.
Geographic footprint. Globex Healthcare & Pharma Inc is headquartered in SOUTH PLAINFIELD, NJ under NAICS code 561320, and places H-1B workers across 5 states, most heavily in NJ, PA, TX. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.
Where Globex Healthcare & Pharma Inc ranks. By H-1B petition volume, Globex Healthcare & Pharma Inc is #21,197 of 119,880 employers nationally and #1,653 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.
Certification Rate
100%
Avg. Salary
$80,603
Median Salary
$80,603
Total Workers
7
Globex Healthcare & Pharma Inc vs a peer vs the national average, from DOL LCA data.
Compensation range for H-1B positions at Globex Healthcare & Pharma Inc
Wage vs. DOL Minimum
+0.8%
national avg +17.9%
Typical DOL Wage Level
Entry (Level I)
57.1% of petitions
Full-Time Positions
100%
Primary Worksite County
MIDDLESEX, NJ
42.9% of petitions
H-1B filing trends from FY2024 to FY2025
| Year | Petitions | Certified | Avg. Salary |
|---|---|---|---|
| FY2024 | 2 | 2 | $84,688 |
| FY2025 | 5 | 5 | $78,969 |
Most frequently sponsored job titles at Globex Healthcare & Pharma Inc
| Job Title | Petitions | Avg. Salary |
|---|---|---|
| CLINICAL DATA MANAGER | 3 | $96,408 |
| SAFETY & PHARMACOVIGILANCE SPECIALIST | 1 | $82,763 |
| REGULATORY AFFAIRS SPECIALIST | 1 | $63,357 |
| QUALITY CONTROL CHEMIST | 1 | $61,069 |
| QUALITY CONTROL ASSOCIATE | 1 | $67,808 |
Where Globex Healthcare & Pharma Inc places H-1B workers across the United States
Latest H-1B labor condition applications filed by Globex Healthcare & Pharma Inc
| Job Title | Location | Salary | Status | Year |
|---|---|---|---|---|
| SAFETY & PHARMACOVIGILANCE SPECIALIST | SOUTH PLAINFIELD, NJ | $82,763 | Certified | FY2025 |
| QUALITY CONTROL ASSOCIATE | HARRISBURG, PA | $67,808 | Certified | FY2025 |
| CLINICAL DATA MANAGER | SOUTH PLAINFIELD, NJ | $82,763 | Certified | FY2025 |
| REGULATORY AFFAIRS SPECIALIST | HOUSTON, TX | $63,357 | Certified | FY2025 |
| CLINICAL DATA MANAGER | SAN FRANCISCO, CA | $98,155 | Certified | FY2025 |
| QUALITY CONTROL CHEMIST | SALT LAKE CITY, UT | $61,069 | Certified | FY2024 |
| CLINICAL DATA MANAGER | SOUTH PLAINFIELD, NJ | $108,306 | Certified | FY2024 |
Other H-1B sponsors based in NJ, ranked by petition volume
Compare Globex Healthcare & Pharma Inc vs Ernst & Young US LLP side-by-side →
Essential resources for understanding H-1B visa sponsorship
Step-by-step guide from LCA filing to work authorization
Understanding prevailing wage levels I through IV
How to read and interpret DOL LCA disclosure data
Compare salaries by occupation, state, and wage level
Globex Healthcare & Pharma Inc has filed 7 H-1B LCA petitions covering 7 worker positions from FY2024 to FY2025.
Globex Healthcare & Pharma Inc has a 100% certification rate, with 7 out of 7 petitions certified.
The average H-1B salary at Globex Healthcare & Pharma Inc is $80,603. Salaries range from $61,069 to $108,306.
The top H-1B job titles at Globex Healthcare & Pharma Inc include CLINICAL DATA MANAGER, SAFETY & PHARMACOVIGILANCE SPECIALIST, REGULATORY AFFAIRS SPECIALIST. The most common position is CLINICAL DATA MANAGER with 3 petitions at an average salary of $96,408.
Globex Healthcare & Pharma Inc is headquartered in SOUTH PLAINFIELD, NJ. Their H-1B workers are distributed across 5 states, with the most positions in NJ, PA, TX.
No, Globex Healthcare & Pharma Inc is not classified as H-1B dependent.
Globex Healthcare & Pharma Inc filed 2 petitions in FY2024 and 5 in FY2025. Average salary changed from $84,688 to $78,969.
H-1B visa petition data is sourced from the U.S. Department of Labor (DOL) Labor Condition Application (LCA) disclosure files. Data covers fiscal years 2023 through 2026. Salary figures reflect amounts listed on LCA petitions, not actual compensation paid. Certification of an LCA does not guarantee visa approval.
Source: DOL Foreign Labor Performance Data
Source: U.S. Department of Labor, Office of Foreign Labor Certification, LCA Disclosure Data (FY2023–FY2026)
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the U.S. Department of Labor LCA disclosure files. Consult a qualified professional before making decisions based on this data.
Read our methodology , how this data is sourced, computed, and verified.
Every figure on PlainVisa is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.